[{"@context":"https:\/\/schema.org\/","@type":"Article","@id":"https:\/\/www.trixi.sk\/spolocnost-musi-zaplatit-4-7-mld-dolarov-pre-udajne-rakovinotvorne-produkty\/#Article","mainEntityOfPage":"https:\/\/www.trixi.sk\/spolocnost-musi-zaplatit-4-7-mld-dolarov-pre-udajne-rakovinotvorne-produkty\/","headline":"Spolo\u010dnos\u0165 mus\u00ed zaplati\u0165 4,7 mld. dol\u00e1rov pre \u00fadajne rakovinotvorn\u00e9 produkty","name":"Spolo\u010dnos\u0165 mus\u00ed zaplati\u0165 4,7 mld. dol\u00e1rov pre \u00fadajne rakovinotvorn\u00e9 produkty","description":"Verdikt prich\u00e1dza ako farmaceutick\u00fd gigant bojuje okolo 9 000 pr\u00e1vnych pr\u00edpadov, ktor\u00e9 zah\u0155\u0148aj\u00fa svoj podpisov\u00fd detsk\u00fd pr\u00e1\u0161ok. J & J povedal, \u017ee je „hlboko sklaman\u00fd“ a pl\u00e1nuje sa odvola\u0165. V \u0161es\u0165t\u00fd\u017ed\u0148ovom klinickom sk\u00fa\u0161an\u00ed \u017eeny a ich rodiny uviedli, \u017ee po…","datePublished":"2025-03-05","dateModified":"2025-03-05","author":{"@type":"Person","@id":"https:\/\/www.trixi.sk\/author\/#Person","name":"","url":"https:\/\/www.trixi.sk\/author\/","identifier":1,"image":{"@type":"ImageObject","@id":"https:\/\/secure.gravatar.com\/avatar\/e32c915fa5b274a4469e3ef5c1f9837e76577a60613858c5c8a74a3de98e33bc?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e32c915fa5b274a4469e3ef5c1f9837e76577a60613858c5c8a74a3de98e33bc?s=96&d=mm&r=g","height":96,"width":96}},"publisher":{"@type":"Organization","name":"trixi.sk","logo":{"@type":"ImageObject","@id":"\/logo.png","url":"\/logo.png","width":600,"height":60}},"image":{"@type":"ImageObject","@id":"https:\/\/www.trixi.sk\/wp-content\/uploads\/img_a289576_w16537_t1531753214.jpg","url":"https:\/\/www.trixi.sk\/wp-content\/uploads\/img_a289576_w16537_t1531753214.jpg","height":0,"width":0},"url":"https:\/\/www.trixi.sk\/spolocnost-musi-zaplatit-4-7-mld-dolarov-pre-udajne-rakovinotvorne-produkty\/","about":["Produkty"],"wordCount":487,"articleBody":"Verdikt prich\u00e1dza ako farmaceutick\u00fd gigant bojuje okolo 9 000 pr\u00e1vnych pr\u00edpadov, ktor\u00e9 zah\u0155\u0148aj\u00fa svoj podpisov\u00fd detsk\u00fd pr\u00e1\u0161ok. J & J povedal, \u017ee je „hlboko sklaman\u00fd“ a pl\u00e1nuje sa odvola\u0165.V \u0161es\u0165t\u00fd\u017ed\u0148ovom klinickom sk\u00fa\u0161an\u00ed \u017eeny a ich rodiny uviedli, \u017ee po dek\u00e1dach pou\u017e\u00edvaj\u00fa detsk\u00fd pr\u00e1\u0161ok a in\u00e9 masteneck\u00e9 v\u00fdrobky na rakovinu vaje\u010dn\u00edkov. Z 22 \u017eien zast\u00fapen\u00fdch v tomto pr\u00edpade \u0161est zomrelo na rakovinu vaje\u010dn\u00edkov. Ich pr\u00e1vnici tvrdili, \u017ee spolo\u010dnos\u0165 vie, \u017ee jej talku bol od 70. rokov zne\u010disten\u00fd azbestom, ale spotrebite\u013eom neinformoval o rizik\u00e1ch.Nekal\u00fd procesMastenec je miner\u00e1l a niekedy sa nach\u00e1dza v zemi v tesnej bl\u00edzkosti azbestu. Spolo\u010dnos\u0165 J & J poprela, \u017ee jej v\u00fdrobky v\u00f4bec obsahovali azbest a trvali na tom, \u017ee nesp\u00f4sobuj\u00fa rakovinu.Farmaceutick\u00fd gigant dodal, \u017ee nieko\u013eko \u0161t\u00fadi\u00ed uk\u00e1zalo, \u017ee jeho mastenec je bezpe\u010dn\u00fd a uviedol, \u017ee verdikt je produktom „z\u00e1sadne nespravodliv\u00e9ho procesu“.US Food and Drug Administration (FDA) objednal \u0161t\u00fadiu o r\u00f4znych vzork\u00e1ch talku, vr\u00e1tane J & J, od roku 2009 do roku 2010. V \u017eiadnom z nich nebol n\u00e1jden\u00fd azbest. Prokur\u00e1tor ozn\u00e1mila, \u017ee FDA a Johnson & Johnson pou\u017eili nespr\u00e1vne testovacie met\u00f3dy.Charitat\u00edvna lie\u010dba rakoviny vaje\u010dn\u00edkov v Spojenom kr\u00e1\u013eovstve, Ovacome, priniesla inform\u00e1cie o tejto problematike. Hovor\u00ed sa, \u017ee u\u017e nieko\u013eko rokov existuj\u00fa obavy, \u017ee pou\u017e\u00edvanie mastenca v oblasti pohlavn\u00fdch org\u00e1nov m\u00f4\u017ee zv\u00fd\u0161i\u0165 riziko rakoviny vaje\u010dn\u00edkov, no pod\u013ea v\u00fdskumu to nebolo dok\u00e1zan\u00e9 a s\u00fa potrebn\u00e9 \u010fal\u0161ie \u0161t\u00fadie.Z\u00e1znam verdiktuVerdikt je najv\u00e4\u010d\u0161ou v\u00fdplatou, ktor\u00fa spolo\u010dnos\u0165 J & J \u010delila obvineniam. Od\u0161kodnenie za trestn\u00e9 \u010diny je \u010dasto zn\u00ed\u017een\u00e9 s\u00fadnym sudcom alebo odvolan\u00edm a spolo\u010dnosti J & J sa podarilo zru\u0161i\u0165 nieko\u013eko verdiktov poroty, z ktor\u00fdch niektor\u00e9 z technick\u00fdch d\u00f4vodov.Predch\u00e1dzaj\u00face rozhodnutie v roku 2017 kalifornskou porotou udelilo 417 mili\u00f3nov dol\u00e1rov \u017eenke, ktor\u00e1 uviedla, \u017ee vyvinula rakovinu vaje\u010dn\u00edkov po pou\u017eit\u00ed produktov firmy, vr\u00e1tane detsk\u00e9ho pr\u00e1\u0161ku.Sudca v\u0161ak nesk\u00f4r zru\u0161il tento verdikt a nieko\u013eko \u010fal\u0161\u00edch pr\u00e1vnych probl\u00e9mov J & J e\u0161te treba rozhodn\u00fa\u0165. V\u00e4\u010d\u0161ina z 22 \u017eien bola mimo \u0161t\u00e1tu Missouri. Prezent\u00e1cia ich kombinovan\u00fdch pr\u00edpadov na takomto s\u00fade je zn\u00e1ma ako forum shopping. To bude jeden z prvkov napadnut\u00fdch spolo\u010dnos\u0165ou Johnson & Johnson v odvolan\u00ed.Johnson & Johnson tvrd\u00ed: „Ka\u017ed\u00fd verdikt proti Johnson & Johnson v tomto s\u00fade, ktor\u00fd pre\u0161iel odvolac\u00edm procesom, bol obr\u00e1ten\u00fd a viacn\u00e1sobn\u00e9 chyby pr\u00edtomn\u00e9 v tomto procese boli hor\u0161ie ne\u017e v predch\u00e1dzaj\u00facich sk\u00fa\u0161kach, ktor\u00e9 boli obr\u00e1ten\u00e9.“                                                                                                                                                                                                                                                                                                                                                                                        3.5\/5 - (8 votes)        "},{"@context":"https:\/\/schema.org\/","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Spolo\u010dnos\u0165 mus\u00ed zaplati\u0165 4,7 mld. dol\u00e1rov pre \u00fadajne rakovinotvorn\u00e9 produkty","item":"https:\/\/www.trixi.sk\/spolocnost-musi-zaplatit-4-7-mld-dolarov-pre-udajne-rakovinotvorne-produkty\/#breadcrumbitem"}]}]